Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.
Qian Q, Yang B, Lu X, Zhang Z, Chen J, Kuang Y, Zhang C, Man X, Su J, Ma C, Zhou G, Li B, Situ X, Ma X, Yang Y, Feng Y, Chen S, Zhan Y, Chen Q, Zhu X, Wang J, Zhang F.
Qian Q, et al. Among authors: zhang f.
J Eur Acad Dermatol Venereol. 2025 Jan 4. doi: 10.1111/jdv.20511. Online ahead of print.
J Eur Acad Dermatol Venereol. 2025.
PMID: 39754490
No abstract available.